| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in antithrombotic therapy of acute myocardial infarction
|
Gensini, G.F.
|
|
1999
|
138 |
2S |
p. S171-S176
6 p.
|
artikel
|
| 2 |
Clinical epidemiology of acute myocardial infarction
|
Tavazzi, Luigi
|
|
1999
|
138 |
2S |
p. S48-S54
7 p.
|
artikel
|
| 3 |
Cost-effectiveness of reperfusion strategies
|
Parmley, William W.
|
|
1999
|
138 |
2S |
p. S142-S146
5 p.
|
artikel
|
| 4 |
Current role of stenting in acute myocardial infarction
|
Antoniucci, David
|
|
1999
|
138 |
2S |
p. S147-S152
6 p.
|
artikel
|
| 5 |
Do new devices add to the results of PTCA in acute myocardial infarction?
|
Moses, Jeffrey
|
|
1999
|
138 |
2S |
p. S158-S163
6 p.
|
artikel
|
| 6 |
Early predictors of left ventricular remodeling after acute myocardial infarction
|
Bolognese, Leonardo
|
|
1999
|
138 |
2S |
p. S79-S83
5 p.
|
artikel
|
| 7 |
From plaque biology to clinical setting
|
Arbustini, Eloisa
|
|
1999
|
138 |
2S |
p. S55-S60
6 p.
|
artikel
|
| 8 |
Gene therapy for myocardial angiogenesis
|
Losordo, Douglas W.
|
|
1999
|
138 |
2S |
p. S132-S141
10 p.
|
artikel
|
| 9 |
How to use ACE-inhibitors, β-blockers, and newer therapies in AMI
|
Maggioni, Aldo P.
|
|
1999
|
138 |
2S |
p. S183-S187
5 p.
|
artikel
|
| 10 |
IIb/IIIa Receptor blockade in acute myocardial infarction
|
Ferguson, James J.
|
|
1999
|
138 |
2S |
p. S164-S170
7 p.
|
artikel
|
| 11 |
Introduction
|
Antoniucci, David
|
|
1999
|
138 |
2S |
p. S47-
1 p.
|
artikel
|
| 12 |
Ischemic preconditioning, myocardial stunning, and hibernation: Basic aspects
|
Ferraria , Roberto
|
|
1999
|
138 |
2S |
p. S61-S68
8 p.
|
artikel
|
| 13 |
Low-dose fibrinolytics and glycoprotein IIb/IIIa receptor blockade for the treatment of acute myocardial infarction
|
Ferrario, Maurizio
|
|
1999
|
138 |
2S |
p. S121-S125
5 p.
|
artikel
|
| 14 |
Microvascular integrity after reperfusion therapy
|
Agati, Luciano
|
|
1999
|
138 |
2S |
p. S76-S78
3 p.
|
artikel
|
| 15 |
Old and new paradigms on diastolic function in acute myocardial infarction
|
Popović, Aleksandar D.
|
|
1999
|
138 |
2S |
p. S84-S88
5 p.
|
artikel
|
| 16 |
Optimal management of acute myocardial infarction at the dawn of the next millennium
|
Gersh, Bernard J.
|
|
1999
|
138 |
2S |
p. S188-S202
15 p.
|
artikel
|
| 17 |
Optimal treatment of patients with acute coronary syndromes and non–ST-elevation myocardial infarction
|
White, Harvey D.
|
|
1999
|
138 |
2S |
p. S105-S114
10 p.
|
artikel
|
| 18 |
Primary PTCA versus thrombolytic therapy: An evidence-based summary
|
Ryan, Thomas J.
|
|
1999
|
138 |
2S |
p. S96-S104
9 p.
|
artikel
|
| 19 |
Primary stenting and glycoprotein IIb/IIIa inhibitors in acute myocardial infarction
|
Colombo, Antonio
|
|
1999
|
138 |
2S |
p. S153-S157
5 p.
|
artikel
|
| 20 |
Recanalization versus reperfusion for myocardial survival and preservation of ventricular geometry
|
L’Abbate, Antonio
|
|
1999
|
138 |
2S |
p. S89-S95
7 p.
|
artikel
|
| 21 |
Reperfusion injury: Experimental evidence and clinical implications
|
Ambrosio, Giuseppe
|
|
1999
|
138 |
2S |
p. S69-S75
7 p.
|
artikel
|
| 22 |
Reperfusion therapy in cardiogenic shock complicating acute myocardial infarction
|
Santoro, Giovanni Maria
|
|
1999
|
138 |
2S |
p. S126-S131
6 p.
|
artikel
|
| 23 |
Statin trials and goals of cholesterol-lowering therapy after AMI
|
Pedersen, Terje R.
|
|
1999
|
138 |
2S |
p. S177-S182
6 p.
|
artikel
|
| 24 |
What do new lytics add to t-PA?
|
Van de Werf, Frans
|
|
1999
|
138 |
2S |
p. S115-S120
6 p.
|
artikel
|
Tijdschrift beschrijving